Clinical Phase 3 Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases
Latest Information Update: 12 Mar 2020
At a glance
- Drugs Immune globulin (Primary)
- Indications Bacterial infections; Primary immunodeficiency diseases
- Focus Registrational; Therapeutic Use
- Sponsors Octapharma
Most Recent Events
- 18 Jun 2019 New trial record